These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 9676739

  • 1. Invited review: Cholinesterase inhibitors for Alzheimer's disease therapy: from tacrine to future applications.
    Giacobini E.
    Neurochem Int; 1998; 32(5-6):413-9. PubMed ID: 9676739
    [Abstract] [Full Text] [Related]

  • 2. Cholinesterase inhibitors in the treatment of Alzheimer's disease: a comparison of tolerability and pharmacology.
    Nordberg A, Svensson AL.
    Drug Saf; 1998 Dec; 19(6):465-80. PubMed ID: 9880090
    [Abstract] [Full Text] [Related]

  • 3. Pharmacodynamic-tolerability relationships of cholinesterase inhibitors for Alzheimer's disease.
    Imbimbo BP.
    CNS Drugs; 2001 Dec; 15(5):375-90. PubMed ID: 11475943
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Design of new drugs for the treatment of Alzheimer's disease based on tacrine structure.
    de Aquino RA, Modolo LV, Alves RB, de Fatima A.
    Curr Drug Targets; 2013 Mar; 14(3):378-97. PubMed ID: 23176115
    [Abstract] [Full Text] [Related]

  • 7. WITHDRAWN: Tacrine for Alzheimer's disease.
    Qizilbash N, Birks J, Lopez Arrieta J, Lewington S, Szeto S.
    Cochrane Database Syst Rev; 2007 Jul 18; (3):CD000202. PubMed ID: 17636619
    [Abstract] [Full Text] [Related]

  • 8. Pharmacology and clinical efficacy of cholinesterase inhibitors.
    Jann MW.
    Am J Health Syst Pharm; 1998 Nov 01; 55 Suppl 2():S22-5. PubMed ID: 9809108
    [Abstract] [Full Text] [Related]

  • 9. [Tacrine and its derivatives in the therapy of Alzheimers disease].
    Korábečný J, Spilovská K, Benek O, Musílek K, Soukup O, Kuča K.
    Ceska Slov Farm; 2012 Oct 01; 61(5):210-21. PubMed ID: 23256654
    [Abstract] [Full Text] [Related]

  • 10. Tacrine, and Alzheimer's treatments.
    Summers WK.
    J Alzheimers Dis; 2006 Oct 01; 9(3 Suppl):439-45. PubMed ID: 16914883
    [Abstract] [Full Text] [Related]

  • 11. [Mechanisms of neuroprotective effects of therapeutic acetylcholinesterase inhibitors used in treatment of Alzheimer's disease].
    Takatori Y.
    Yakugaku Zasshi; 2006 Aug 01; 126(8):607-16. PubMed ID: 16880719
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Tacrine in Alzheimer's disease.
    Levy R.
    Lancet; 1989 Aug 05; 2(8658):329. PubMed ID: 2569126
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Multitarget compounds bearing tacrine- and donepezil-like structural and functional motifs for the potential treatment of Alzheimer's disease.
    Ismaili L, Refouvelet B, Benchekroun M, Brogi S, Brindisi M, Gemma S, Campiani G, Filipic S, Agbaba D, Esteban G, Unzeta M, Nikolic K, Butini S, Marco-Contelles J.
    Prog Neurobiol; 2017 Apr 05; 151():4-34. PubMed ID: 26797191
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Donepezil: new preparation. Moderate efficacy in Alzheimer's disease.
    Prescrire Int; 1998 Oct 05; 7(37):146-7. PubMed ID: 10915420
    [Abstract] [Full Text] [Related]

  • 20. Pharmacodynamics of cholinesterase inhibitors suggests add-on therapy with a low-dose carbamylating inhibitor in patients on long-term treatment with rapidly reversible inhibitors.
    Darreh-Shori T, Hosseini SM, Nordberg A.
    J Alzheimers Dis; 2014 Oct 05; 39(2):423-40. PubMed ID: 24217282
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.